175 related articles for article (PubMed ID: 28574630)
1. High-mobility group box-1 contributes tumor angiogenesis under interleukin-8 mediation during gastric cancer progression.
Chung HW; Lim JB
Cancer Sci; 2017 Aug; 108(8):1594-1601. PubMed ID: 28574630
[TBL] [Abstract][Full Text] [Related]
2. Combined targeting of high-mobility group box-1 and interleukin-8 to control micrometastasis potential in gastric cancer.
Chung HW; Jang S; Kim H; Lim JB
Int J Cancer; 2015 Oct; 137(7):1598-609. PubMed ID: 25821182
[TBL] [Abstract][Full Text] [Related]
3. Gastric cancer-derived mesenchymal stem cells prompt gastric cancer progression through secretion of interleukin-8.
Li W; Zhou Y; Yang J; Zhang X; Zhang H; Zhang T; Zhao S; Zheng P; Huo J; Wu H
J Exp Clin Cancer Res; 2015 May; 34(1):52. PubMed ID: 25986392
[TBL] [Abstract][Full Text] [Related]
4. Xiaotan Sanjie decoction inhibits angiogenesis in gastric cancer through Interleukin-8-linked regulation of the vascular endothelial growth factor pathway.
Shi J; Lu Y; Wei P
J Ethnopharmacol; 2016 Aug; 189():230-7. PubMed ID: 27224240
[TBL] [Abstract][Full Text] [Related]
5. MACC-1 Promotes Endothelium-Dependent Angiogenesis in Gastric Cancer by Activating TWIST1/VEGF-A Signal Pathway.
Wang L; Zhou R; Zhao Y; Dong S; Zhang J; Luo Y; Huang N; Shi M; Bin J; Liao Y; Liao W
PLoS One; 2016; 11(6):e0157137. PubMed ID: 27280289
[TBL] [Abstract][Full Text] [Related]
6. [High mobility group box-1 protein activates endothelial cells to produce cytokines and has synergistic effect with lipopolysaccharide in inducing interleukin-6 release].
Liu JH; Li ZJ; Tang J; Liu YW; Zhao L; Deng P; Jiang Y
Zhonghua Yi Xue Za Zhi; 2006 May; 86(17):1191-5. PubMed ID: 16796861
[TBL] [Abstract][Full Text] [Related]
7. Tumor-derived exosomes induce N2 polarization of neutrophils to promote gastric cancer cell migration.
Zhang X; Shi H; Yuan X; Jiang P; Qian H; Xu W
Mol Cancer; 2018 Oct; 17(1):146. PubMed ID: 30292233
[TBL] [Abstract][Full Text] [Related]
8. Role of Extracellular High-Mobility Group Box-1 as a Therapeutic Target of Gastric Cancer.
Takaki W; Konishi H; Matsubara D; Shoda K; Arita T; Kataoka S; Shibamoto J; Furuke H; Takabatake K; Shimizu H; Komatsu S; Shiozaki A; Kubota T; Okamoto K; Otsuji E
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328684
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-1 receptor antagonist inhibits angiogenesis in gastric cancer.
Gong Z; Ma J; Su H; Guo T; Cai H; Chen Q; Zhao X; Qi J; Du J
Int J Clin Oncol; 2018 Aug; 23(4):659-670. PubMed ID: 29344744
[TBL] [Abstract][Full Text] [Related]
10. The effect of Vasohibin-1 expression and tumor-associated macrophages on the angiogenesis in vitro and in vivo.
Shen Z; Yan Y; Ye C; Wang B; Jiang K; Ye Y; Mustonen H; Puolakkainen P; Wang S
Tumour Biol; 2016 Jun; 37(6):7267-76. PubMed ID: 26666821
[TBL] [Abstract][Full Text] [Related]
11. CEACAM6 promotes tumor angiogenesis and vasculogenic mimicry in gastric cancer via FAK signaling.
Zang M; Zhang Y; Zhang B; Hu L; Li J; Fan Z; Wang H; Su L; Zhu Z; Li C; Yan C; Gu Q; Liu B; Yan M
Biochim Biophys Acta; 2015 May; 1852(5):1020-8. PubMed ID: 25703140
[TBL] [Abstract][Full Text] [Related]
12. CHIP functions as a novel suppressor of tumour angiogenesis with prognostic significance in human gastric cancer.
Wang S; Wu X; Zhang J; Chen Y; Xu J; Xia X; He S; Qiang F; Li A; Shu Y; Røe OD; Li G; Zhou JW
Gut; 2013 Apr; 62(4):496-508. PubMed ID: 22535373
[TBL] [Abstract][Full Text] [Related]
13. Cancer-associated fibroblasts promote angiogenesis in gastric cancer through galectin-1 expression.
Tang D; Gao J; Wang S; Ye N; Chong Y; Huang Y; Wang J; Li B; Yin W; Wang D
Tumour Biol; 2016 Feb; 37(2):1889-99. PubMed ID: 26323258
[TBL] [Abstract][Full Text] [Related]
14. Redox status of high-mobility group box 1 performs a dual role in angiogenesis of colorectal carcinoma.
Zhu L; Ren L; Chen Y; Fang J; Ge Z; Li X
J Cell Mol Med; 2015 Sep; 19(9):2128-35. PubMed ID: 26099505
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-27b, microRNA-101 and microRNA-128 inhibit angiogenesis by down-regulating vascular endothelial growth factor C expression in gastric cancers.
Liu HT; Xing AY; Chen X; Ma RR; Wang YW; Shi DB; Zhang H; Li P; Chen HF; Li YH; Gao P
Oncotarget; 2015 Nov; 6(35):37458-70. PubMed ID: 26460960
[TBL] [Abstract][Full Text] [Related]
16. RNAi-mediated inhibition of Lgr5 leads to decreased angiogenesis in gastric cancer.
Xi HQ; Zhang KC; Li JY; Cui JX; Gao YH; Wei B; Huang D; Chen L
Oncotarget; 2017 May; 8(19):31581-31591. PubMed ID: 28404940
[TBL] [Abstract][Full Text] [Related]
17. Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial‑to‑mesenchymal transition in colon and breast cancers.
Katkoori VR; Basson MD; Bond VC; Manne U; Bumpers HL
Oncotarget; 2015 Sep; 6(29):27763-77. PubMed ID: 26318034
[TBL] [Abstract][Full Text] [Related]
18. EphA3 contributes to tumor growth and angiogenesis in human gastric cancer cells.
Lv XY; Wang J; Huang F; Wang P; Zhou JG; Wei B; Li SH
Oncol Rep; 2018 Oct; 40(4):2408-2416. PubMed ID: 30066881
[TBL] [Abstract][Full Text] [Related]
19. [High mobility group box-1 stimulates proinflammatory cytokine production in endothelial cells via MAP kinases].
Zhong TY; Tang J; Liu YW; Li ZJ; Chen DY; Zhao MZ; Wang W; Liu JH; Jiang Y
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Aug; 29(8):1517-20. PubMed ID: 19726280
[TBL] [Abstract][Full Text] [Related]
20. ADAMTS5 acts as a tumor suppressor by inhibiting migration, invasion and angiogenesis in human gastric cancer.
Huang J; Sun Y; Chen H; Liao Y; Li S; Chen C; Yang Z
Gastric Cancer; 2019 Mar; 22(2):287-301. PubMed ID: 30105548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
